Humana Inc. (HUM) - Stock Analysis

Last updated: Sep 20, 2026

Research Idea

Research content for general circulation. Not individualized advice. Methodology & Disclosures

The October 2027 Medicare Advantage ratings update put 95% of members in plans rated at least four stars and helped drive an October 9 rally. Shares gained about 7.3% over 21 trading days, but the ratings benefit remains unquantified.

Loading chart data...

Idea window: 10/13/2026 – 10/20/2026Sector: Healthcare

AI Analyst Overview

Last Price
$420.38
Market Cap
$52.05B
1D Return
-3.03%
YTD Return
+65.35%

Loading chart data...

Valuation Metrics

P/E
40.7
P/B
2.7
P/S
0.4
EV/EBITDA
21.4
Div Yield
0.82%

Fundamental Analysis

5.0

Key Financial Insights: • Strong Cash Flow • Rising Leverage • Thin Margins Hum's stronger quarterly cash flow and earnings are offset by rising leverage, tighter liquidity, thin margins, and a materially richer valuation, warranting cautious monitoring.

CashFlow
Valuation

Price Behavior

5.0

Key Price Behavior Insights: • Pullback intensifies • $400 pivotal • Support tested Support Level: $384–$386 Resistance Level: $400–$403 HUM's last-month uptrend is weakening after a sharp pullback to $386.22, with recovery above $400 needed to improve momentum and a break below $384 signaling downside risk.

HUM
Cautious

Sentiment & News

5.0

Key News Insights: • Institutional Accumulation • Cost Pressures • Leadership Update Humana saw strong institutional buying and improving sentiment, though elevated costs, debt concerns, and some stake trimming remain key risks.

Humana
Healthcare
AI

AI Summary

5.0
Neutral

Humana is a margin-recovery turnaround—not a membership-growth story—where shedding ~600,000 unprofitable Medicare Advantage members could restore earnings power, but elevated utilization, regulatory risk, and rising leverage leave little room for execution missteps; investors should wait for sustained medical-cost and margin improvement before underwriting the stock's premium valuation.

Turnaround
UtilizationRisk
MedicareAdvantage
AI summary updated 23 days ago

Description

Humana Inc. is a U.S.-based health and well-being company organized across Retail, Group and Specialty, and Healthcare Services segments. It underwrites Medicare and supplemental benefit plans, manages Medicaid and dual-eligible programs under state and federal contracts, and provides commercial fully insured and administrative services products for employers, along with pharmacy, provider and home health services. As of year-end 2021 the company served roughly 17 million medical plan members and about 5 million specialty product members; it was founded in 1961 and is headquartered in Louisville, Kentucky.

Idea History

DateCloseTickerCompanySummaryStatusP/L
Oct 13Oct 20HUMHumana Inc.
The October 2027 Medicare Advantage ratings update put 95% of members in plans rated at least four stars and helped drive an October 9 rally. Shares gained about 7.3% over 21 trading days, but the ratings benefit remains unquantified.
Active+0.0%
Research content for educational purposes only. Not investment advice. All decisions are your responsibility.